As shown in Figure 9, the assays confirmed that CREB3L1, CAPG, and SPINT1 were significantly upregulated in breast cancer group, while GRK3 was significantly downregulated when compared to normal group, respectively. This evidence concerns the gene CREB3L1 and breast cancer.